Home › Hereditary Neoplastic Syndromes › NCT05562778

Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

Evaluation of a Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment in an Underserved Gynecology Population

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* 8 years of age or older.
* Scheduled for a New Patient appointment in the gynecology clinic. Speaks and reads in English.
* Access to a telephone with texting capacity.
* Has not had prior genetic testing for hereditary cancer syndromes.

Exclusion Criteria:

* Under 18 years of age
* Has had previous genetic testing for hereditary cancer syndromes
* Does not read/speak in English
* Does not have access to a phone with texting capabilities

About the study

In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive. This comparison will enable the investigators to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated risk of harboring a familial cancer syndrome in an all-Medicaid gynecology clinic. Furthermore, the investigators aim to evaluate facilitators of inequity in regard to patient access to and utilization of genetic testing services.

What is being tested

• Chatbot (other)

Sponsor: Weill Medical College of Cornell University · Participants: 150 · Started: Jan 15, 2023

Contact the study team

• Melissa K Frey, MD, MS · Phone: 212-746-3049

Official record on ClinicalTrials.gov — NCT05562778

Locations in the U.S.

Conditions

• Hereditary Neoplastic Syndromes

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.